http://www.law360.com/ Latest articles for organization: Watson Pharmaceuticals Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/135646 A Pennsylvania jury has ruled that two Pfizer Inc. units are on the hook for at least $6.3 million in compensatory damages to an Illinois woman who developed breast cancer after she began taking popular menopause drugs Prempro and Provera. http://www.law360.com/articles/135646 http://www.law360.com/articles/133989 Cephalon Inc. and Barr Pharmaceuticals LLC have called a truce in their legal battles over the cancer painkiller Fentora. http://www.law360.com/articles/133989 http://www.law360.com/articles/132605 U.S. federal agents searched the office of South Florida firm Rothstein Rosenfeldt Adler PA as part of an investigation into allegations that high-flying attorney Scott W. Rothstein misappropriated millions of dollars in investor funds. http://www.law360.com/articles/132605 http://www.law360.com/articles/132433 While the verdict officially remains under wraps, word is spreading that a Pennsylvania jury has ordered Pfizer Inc. to fork over $75 million in punitive damages to a woman who developed invasive breast cancer after she began taking the popular menopause drug Prempro. http://www.law360.com/articles/132433 http://www.law360.com/articles/131998 South Florida firm Rothstein Rosenfeldt Adler PA appears to have come undone after equity partner Stuart A. Rosenfeldt filed a suit strongly suggesting the firm's other principal — political impresario and local celebrity Scott W. Rothstein — is engulfed in a multimillion-dollar Ponzi scandal. http://www.law360.com/articles/131998 http://www.law360.com/articles/131744 Solvay Pharmaceuticals Inc. has asked a judge to dismiss three indirect purchaser cases from the multidistrict litigation over allegedly anti-competitive patent litigation pacts related to the drug AndroGel, arguing that the settlements allow for generic competition years before the AndroGel patent expires. http://www.law360.com/articles/131744 http://www.law360.com/articles/131102 Warner Chilcott PLC's allegations that Lupin Ltd. has infringed patents for its birth control drugs Loestrin 24 Fe and Femcon Fe will move forward in the U.S. District Court for the District of Delaware, now that the company has dropped identical protective suits in another court. http://www.law360.com/articles/131102 http://www.law360.com/articles/130896 A unit of specialty pharmaceutical firm Watson Pharmaceuticals Inc. has struck a deal with Barr Pharmaceuticals Inc. that resolves patent litigation over Watson’s Oxytrol and grants Barr a license to eventually market a generic version of the overactive bladder treatment. http://www.law360.com/articles/130896 http://www.law360.com/articles/130536 In a one-two punch to Pfizer Inc., a Philadelphia jury has reportedly awarded punitive damages in addition to $3.7 million in compensatory damages to a woman who developed invasive breast cancer after she began taking Prempro, which is made by the company’s Wyeth unit. http://www.law360.com/articles/130536 http://www.law360.com/articles/129314 A federal judge has rejected Mutual Pharmaceutical Co. Inc.'s request for a preliminary injunction barring Watson Pharmaceuticals Inc. from claiming that its version of gout treatment colchicine is approved by the U.S. Food and Drug Administration, allegedly in violation of the Lanham Act. http://www.law360.com/articles/129314 http://www.law360.com/articles/127378 Teva Women’s Health Inc. has filed a patent infringement suit against Lupin Ltd. over its plans to market a generic version of Seasonale, an oral contraceptive that limits the number of menstrual periods women have in a year. http://www.law360.com/articles/127378 http://www.law360.com/articles/124967 Direct purchaser plaintiffs in an antitrust class action alleging Biovail Corp. and GlaxoSmithKline PLC conspired to stifle the market for a generic version of antidepressant Wellbutrin XL have asked defendants to turn over market projections depicting how the generic would affect sales and prices for the branded bupropion. http://www.law360.com/articles/124967 http://www.law360.com/articles/124172 Less than a week after asking a court to dismiss Bristol-Myers Squibb Co. from a suit, the state of Arizona has revealed that the parties have reached a $900,000 settlement that will put to rest allegations that the pharmaceutical giant schemed to artificially boost average wholesale drug prices. http://www.law360.com/articles/124172 http://www.law360.com/articles/122825 The state of Arizona has asked a court to dismiss Bristol-Myers Squibb Co. from multidistrict litigation accusing a number of pharmaceutical companies of scheming to artificially boost average wholesale drug prices, following a settlement agreement between the two parties. http://www.law360.com/articles/122825 http://www.law360.com/articles/121981 Ireland-based Warner Chilcott PLC’s U.S. unit has filed two lawsuits accusing generic-drug maker Lupin Ltd. of violating patents for birth control drugs Loestrin 24 Fe and Femcon Fe. http://www.law360.com/articles/121981 http://www.law360.com/articles/120059 Abrika Pharmaceuticals Inc. has asked the court in charge of antitrust litigation against Biovail Corp. and GlaxoSmithKline PLC over the antidepressant Wellbutrin XL to let it intervene in the case to fight the direct purchaser plaintiffs' bid for documents from patent litigation Biovail brought against Abrika in Florida. http://www.law360.com/articles/120059 http://www.law360.com/articles/118495 Massachusetts Attorney General Martha Coakley has accused Mylan Laboratories Inc. and other pharmaceutical companies of systematically reporting false and inflated prices for products purchased by the state's Medicaid program that resulted in millions of dollars in overpayments by taxpayers. http://www.law360.com/articles/118495 http://www.law360.com/articles/118419 Following in the footsteps of the federal courts, a state court judge in California has ruled that Bayer AG did not violate the state's antitrust law when it paid Barr Pharmaceuticals Inc. to delay the entry of a generic version of the antibiotic Cipro. http://www.law360.com/articles/118419 http://www.law360.com/articles/116228 Sanofi-Aventis has reached a deal with Watson Pharmaceuticals Inc. in a long-standing patent infringement suit over Watson’s attempt to market a generic version of the blockbuster blood thinner Plavix. http://www.law360.com/articles/116228 http://www.law360.com/articles/115927 The direct purchaser plaintiffs in an antitrust class action alleging that Biovail Corp. and GlaxoSmithKline PLC conspired to stifle the market for a generic version of antidepressant Wellbutrin XL have charged ahead with their battle to have a set of documents related to several underlying patent cases released for discovery. http://www.law360.com/articles/115927